Keyphrases
Cancer Drugs
100%
Obese Mice
100%
Adipose Tissue
100%
Proliferator-activated Receptor-γ
100%
Coactivator
100%
Dasatinib
100%
Adverse Effects
100%
Glucose Tolerance
100%
Chronic Myeloid Leukemia
25%
Inducer
25%
Impaired Glucose Tolerance
12%
Tyrosine Kinase Inhibitor
12%
Leaner Mouse
12%
Peroxisome Proliferator-activated Receptor
12%
Gene Expression
12%
Beneficial Effects
12%
Glucose-6-phosphatase (G6Pase)
12%
Diet-induced Obesity
12%
Primary Adipocytes
12%
Melanoma Cells
12%
Glucose Intolerance
12%
Protein Content
12%
Adipocyte
12%
Epididymal White Adipose Tissue
12%
Diet-induced Obese Mice
12%
MRNA Expression
12%
Isolated Mitochondria
12%
Gluconeogenesis
12%
Phosphoenolpyruvate Carboxylase
12%
Immunology and Microbiology
Mouse Mutant
100%
Adipocyte
100%
Adipose Tissue
100%
Myeloid
66%
Ob/Ob Mouse
33%
Melanoma Cell
33%
White Adipose Tissue
33%
Gene Expression
33%
Leaner Mutant Mouse
33%
Protein Content
33%
Gluconeogenesis
33%
Mitochondrion
33%
Tyrosine
33%
Peroxisome
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Receptor
100%
Mouse Mutant
100%
Dasatinib
100%
Messenger RNA
33%
Chronic Myeloid Leukemia
22%
Leaner Mutant Mouse
11%
Melanoma
11%
Diet Induced Obesity
11%
Peroxisome Proliferator Activated Receptor Gamma
11%
Protein Tyrosine Kinase Inhibitor
11%
Glucose Intolerance
11%
Adverse Event
11%
Ob/Ob Mouse
11%
Phosphoenolpyruvate Carboxykinase (GTP)
11%
Glucose 6 Phosphatase
11%
Impaired Glucose Tolerance
11%
Biochemistry, Genetics and Molecular Biology
Dasatinib
100%
Mouse Mutant
100%
Messenger RNA
33%
Adipocyte
33%
Myeloid
22%
Protein Content
11%
Gluconeogenesis
11%
Tyrosine Kinase Inhibitor
11%
Gene Expression
11%
Glucose 6-Phosphatase
11%
Impaired Glucose Tolerance
11%
Phosphoenolpyruvate Carboxykinase
11%
Ob/Ob Mouse
11%
Mitochondrion
11%
Peroxisome Proliferator-Activated Receptor Gamma
11%
Medicine and Dentistry
Glucose 6 Phosphatase
11%
Phosphoenolpyruvate Carboxykinase (GTP)
11%